Correction

Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach (vol 11, 783803, 2022)

FRONTIERS IN ONCOLOGY (2022)

卷 12, 期 -, 页码 -

DOI: 10.3389/fonc.2022.892408

breast cancer; PEMFs; EMT; patient-derived xenograft; chorioallantoic membrane; doxorubicin; TRPC1; chemotherapy

Oncology

点击您的名字以认领此论文并将其添加到您的个人资料中。